Here are five insights:
1. The findings are from a study published online by Alimentary Pharmacology and Therapeutics.
2. The double-blind, sham-controlled, multi-center European study included 44 patients.
3. Prior to the TIF procedure, patients were required to refrain from PPI consumption for at least 10 days.
4. Of the randomized patients treated with the TIF procedure, 59 percent were determined to be in remission after six months as compared to 9 percent of patients in the sham treatment group.
5. The study also reported TIF procedure patients had improved acid reflux time from 8.89 to 3.73. The sham-controlled group had no changes in acid reflux time.
More articles on GI/endoscopy:
ACG elects Dr. Kenneth DeVault president: 5 things to know
Commonwealth Laboratories, Quest Diagnostics sign agreement for IBSchek: 5 key notes
AGA calls for HHS to expand quality programs funding, support
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.